Ишемическая болезнь почек: клиническая картина, патогенез, тактика ведения
Диссертация
Ведение больных атеросклеротическим стенозом почечных артерий следует осуществлять согласно профилактическим стратегиям, принятым в группах высокого риска сердечно-сосудистых осложнений. Обязательна комбинированная антигипертензивная терапия: предпочтительны длительно действующие дигидропиридиновые антагонисты кальция, агонисты И-имидазолиновых рецепторов, в качестве дополнительных препаратов… Читать ещё >
Содержание
- Глава 1. Обзор литературы
- Глава 2. Материал и методы
- Глава 3. Результаты исследования
- 3. 1. Артериальная гипертония при ишемической болезни почек
- 3. 2. Сердечно-сосудистые факторы риска при ишемической болезни почек
- 3. 3. Проявления атеросклероза и сердечно-сосудистые осложнения при ишемической болезни почек
- 3. 4. Признаки почечного поражения при ишемической болезни почек
- 3. 5. Хронические почечные заболевания, сочетающиеся с ишемической болезнью почек
- 3. 6. Морфогенез и ранние маркеры поражения почек при реноваскулярной гипертонии (экспериментальное исследование)
- 3. 7. Ведение больных ишемической болезнью почек
- Глава 4. Обсуждение результатов
- Выводы 243 Практические рекомендации
- Литература
Список литературы
- Арабидзе Г. Г. Злокачественная артериальная гипертония. Кардиология 1985- 1:5−11
- Арабидзе Г. Г., Коздоба O.A., Ушкалов А. Ф., Тарасевич J1.К. Некоторые аспекты диагностики вазоренальной гипертензии. Тер. арх. 1976- 7: 50 53
- Арабидзе Г. Г., Матвеева Л. С., Куценко Л. И. Гипертоническая болезнь и реноваскулярная гипертензия (раздельная гемодинамика почек и ренин-ангиотензин-альдостероновая система). Бюл. ВКНЦ АМН СССР 1978- 2: 53 -60
- Арутюнов Г. П. Статины и острые коронарные синдромы. Мы на пороге нового стандарта лечения. Клин, фармакол. тер. 2001- 10(3): 10−16
- Беленков Ю.Н., Мареев В. Ю. Как мы лечим больных с сердечно-сосудистыми заболеваниями в реальной клинической практике. Тер. архив. 2003- 8: 5 -11
- Бикбов Б.Т., Томилина H.A. О состоянии заместительной терапии больных с хронической почечной недостаточностью в Российской Федерации в 2001 г. Нефрология и диализ. 2004- 6: 4 46
- Бобкова И.Н., Чеботарева Н. В., Козловская Л. В. и др. Экскреция с мочой моноцитарного хемотаксического протеина-1 и трансформирующего фактора роста-ß-l как показатель прогрессирования хронического гломерулонефрита. Тер. арх. 2006- 5: 9−14
- Борисов И.А. Патология почек у лиц пожилого и старческого возраста. Автореферат дисс. докт. мед. наук. М., 1990
- Борисов И.А., Голованова O.E., Гордеев A.B. и соавт. Хроническая почечная недостаточность у лиц пожилого и старческого возраста. Тер архив 1988- 6: 111 116
- Борисов И.А., Давыдов В. М., Перов Ю. Л. и соавт. Структура патологии старческой почки и трудности ее диагностики. Тер. архив. 1986- 8: 37−45
- Борисов И.А., Михайлова H.A., Сура В. В. и соавт. Острая почечная недостаточность у лиц пожилого и старческого возраста. Тер. арх. 1987- 8: 121 128
- Бузиашвили Ю.И. Ишемическая болезнь сердца в сочетании с вазоренальной гипертензией. М., 1994
- Гордеев A.B. Патология почек у больных сахарным диабетом 2 типа пожилого возраста. Автореф. дисс. докт. М., 2002
- Гордеев A.B., Песков Д. Ю. Гетерогенность причин протеинурии у больных инсулиннезависимым сахарным диабетом. Тер. архив 2001- 6: 51 -54
- Князев М.Д., Иманвердиев С. Н. Хирургия вазоренальной гипертонии при двустороннем поражении почечных артерий. В., 1979
- Князев М.Д., Кротовский Г. С., Гавриленко A.B. Реконструктивные операции при хирургическом лечении вазоренальной гипертензии. Кардиология 1976- 5: 26 32
- Кобалава Ж.Д., Котовская Ю. В. Мониторирование артериального давления: методические аспекты и клиническое значение. М., 1999
- Кобалава Ж.Д., Котовская Ю. В., Асеева O.A. и соавт. Клинико-демографические характеристики различных вариантов артериальной гипертонии у пожилых пациентов (по результатам российской научно-практической программы АРГУС). Тер. арх. 2002- 2: 47 51
- Коздоба O.A., Покровский A.B., Вихерт A.M., Арабидзе Г. Г. Значение пункционной биопсии почки при вазоренальной гипертонии: сообщение первое. Кардиология 1977- 10: 51 -56
- Козловская Н.Л. Нефропатия, ассоциированная с первичным антифосфолипидным синдромом: клинико-морфологическая характеристика, диагностика, лечение. Автореф. дисс. докт. М., 2006
- Кутырина И.М., Руденко Т. Е., Швецов М. Ю., Кушнир В. В. Факторы риска сердечно-сосудистых осложнений у больных на додиализной стадии хронической почечной недостаточности. Тер. арх. 2006- 5: 45 50
- Кухарчук В.В., Арабидзе Г. Г., Беличенко И. А. и др. Чрескожная внтрисосудистая баллонная дилатация в лечении больных реноваскулярной гипертонией. Тер. арх. 1981- 8: 72 75
- Кушелевский Б.П., Барац С. С. К симптоматологии и диагностике тромбоза почечных артерий. Клин. мед. 1950- 6: 39−45
- Лопаткин H.A., Мазо Е. Б. Диагностика вазоренальной гипертонии и выбор метода ее лечения. М., 1975
- Мареев В.Ю., Беленков Ю. Н. Хроническая сердечная недостаточность и инсулиннезависимый сахарный диабет: случайная связь или закономерность? Тер. арх. 2003- 10: 5 11
- Марков Х.М. Современные представления о патогенезе реноваскулярной гипертонии. Патол. физиология и эксперим. терапия. 1978- 1:5−15
- Мартынов А.И., Остроумова О. Д., Мамаев В. И. и др. Результаты многоцентровых исследований по изучению эффективности и безопасности гипотензивных препаратов у больных с артериальной гипертензией. Кардиология 2000- 3: 61 67
- Мартынов А.И., Терновой С. К., Остроумова О. Д. и др. Особенности изменения растяжимости аорты на фоне длительной терапии различными классами антигипертензивных препаратов (по данным магнитно-резонансной томографии). Кардиология 2002- 5: 19−22
- Метелева H.A., Козловская Н. Л. Поражение почек при антифосфолипидном синдроме. Тер. арх. 2004- 9: 91 96
- Моисеев С.В. Симпатическая нервная система и артериальная гипертония: новые подходы к лечению. Клин, фармакол. тер. 2002, 11 (3): 34 42
- Моисеев B.C. Метаболические аспекты гипертонической болезни. Тер архив. 1997- 69: 16−18
- Моисеев B.C. Профилактика атеросклероза в популяции или группе риска? Клин, фармакол. тер. 1998- 13: 5- 12
- Моисеев B.C., Кобалава Ж. Д. Артериальная гипертония у лиц старших возрастных групп. М., 2002
- Мухин H.A. Лечение почечной гипертонии. Клин, фармакол. тер. 1992- 1: 38 -41
- Мухин H.A. Профилактическая нефрология и образ жизни современного человека. Тер. архив 1993- 6: 4 7
- Мухин H.A., Моисеев B.C. Кардиоренальные соотношения и риск сердечнососудистых заболеваний. Вестник РАМН 2003- 11: 50 55
- Мухин H.A., Шоничев Д. Г., Балкаров И. М. и соавт. Формирование артериальной гипертонии при уратном тубулоинтерстициальной поражении почек. Тер. архив 1999- 6: 12 24
- Мычка В.Б., Акчурин P.C., Синицин В. Е. и др. Случай своевременной диагностики и оперативного лечения реноваскулярной артериальной гипертонии у больной с фибромускулярной дисплазией почечных артерий и развитием аневризмы. Тер. арх. 2001- 4: 59 -61
- Мясников А.Л. Гипертоническая болезнь и атеросклероз. М., 1965
- Недоступ A.B., Федорова В. И., Дмитриев К. В. Лабильная артериальная гипертензия пожилых пациентов, клинические проявления, состояние вегетативной регуляции кровообращения, подходы к лечению. Клин. мед. 2000- 7: 27 31
- Оганов Р.Г. Профилактическая кардиология: от гипотез к практике. Кардиология 1999- 2: 4 -10
- Оганов Р.Г. Эпидемиология артериальной гипертонии в России и возможности профилактики. Тер. арх. 1997- 69: 3 6
- ОССН ВНОК. Национальные рекомендации по диагностике и лечению хронической сердечной недостаточности (второй пересмотр). Сердечная недостаточность. 2005- 2(36): 2 21
- Пальцев М.А., Кротовский Г. С., Егорова И. А., Щербюк А. Н. Состояние нейроэндокринных аппаратов почек при вазоренальной гипертонии как критерий прогнозирования результата оперативного вмешательства. Арх. пат. 1982- 8: 62−71
- Пальцев М.А., Серов B.B. Эндокринная система почек и нефрогенная гипертензия. Тер. арх. 1987- 8: 110−113
- Пальцев М.А., Яргин C.B., Кротовский Г. С. и др. Значение морфологического исследования почек больных вазоренальной гипертезией для прогноза результатов хирургического лечения. Арх. пат. 1986- 6: 34−40
- Петров В.И., Кротовский Г. С., Пальцев М. А. Вазоренальная гипертензия. М., 1984
- Петровский Б.В., Крылов В. В. Хирургическое лечение реноваскулярной гипертонии. М., 1968
- Покровский A.B. Заболевания аорты и ее ветвей М., 1979
- Покровский A.B. Может ли кардиолог спасти больного от инсульта? Кардиология 2003- 3:4−6
- Покровский A.B., Богатов А. П. Вазоренальная гипертензия. В: Покровский A.B. (ред.) Клиническая ангиология. Руководство. М., 2004
- Покровский A.B., Спиридонов A.A. Диагностика и хирургическое лечение вазоренальной гипертензии. Вестн. АМН СССР 1981- 9: 59−62
- Ратнер H.A., Спивак Г. Л. Симптоматическая почечная гипертония. Тер. арх. 1960- 9: 20
- Секция артериальной гипертонии ВНОК. Профилактика, диагностика и лечение артериальной гипертензии. Российские рекомендации (второй пересмотр). М., 2005
- Семенкова E.H. Системные васкулиты. М., 1988
- Серов В.В., Пальцев М. А. Почки и артериальная гипертензия. М., 1993
- Серов В.В., Пальцев М. А. Эндокринная система почек при нефрогенной артериальной гипертензии: функционально-морфологический анализ. Арх. пат. 1984- 11: 5−15
- Смирнов A.B., Каюков И. Г., Есаян А. М. и др. Превентивный подход в современной нефрологии. Нефрология. 2004- 8(3): 7−14
- Сумароков A.B. Стенозирующий атеросклероз почечных артерий. Сов. мед. 1952- 11:29−32
- Тареев Е.М. Гипертоническая болезнь и атеросклероз. Тер. арх. 1951- 5: 29 -38
- Тареев Е.М. Гипертоническая болезнь и гипертонические синдромы. Кардиология. 1971- 12: 5- 11
- Тареев Е.М. Гипертоническая болезнь. М., 1948
- Тареев Е.М. Нефриты. М., 1958
- Тареев Е.М. Спорные вопросы учения о коронарной и гипертонической болезни. Сов. Мед. 1950- 1:1−5
- Тареева И.Е., Андросова С. О. Влияние ненаркотических анальгетиков и нестероидных противовоспалительных препаратов на почки. Тер. архив 1999- 6: 17−21
- Тареева И.Е., Кутырина И. М. Гипертонический синдром при заболеваниях почек. Клин. мед. 1985- 4: 6 12
- Тареева И.Е., Кутырина И. М., Николаев А. Ю. и др. Пути торможения развития хронической почечной недостаточности. Тер. арх. 2000- 6: 9 -14
- Томилина H.A., Бикбов Б. Т. Эпидемиология хронической почечной недостаточности и новые подходы к классификации и оценке тяжести хронических прогрессирующих заболеваний почек. Тер. арх. 2005- 77(6): 87 -92
- Фаворова О.О., Гусев Д. Е., Чихладзе Н. М., Чазова И. Е. Молекулярно-генетические аспекты неспецифического аортоартериита. Тер. арх. 2002- 9: 81 -85
- Фомин И.В., Мареев В. Ю., Фадеева И. П. и др. Истинная распространенность артериальной гипертонии и современное состояние гипотензивной терапии в Нижегородской области (данные регистра 1998 г.). Кардиология 2000- 9: 33 -37
- Хирманов В.Н. Ишемическая болезнь почек. Тер. архив 2001- 6: 61 -65
- Чазов Е.И. Проблемы первичной и вторичной профилактики сердечнососудистых заболеваний. Тер. арх. 2002- 9: 5 8
- Чазова И.Е., Ратова Л. Г. Комбинированная терапия артериальной гипертонии: просто о сложном. Consilium medicum. 2006- 8(5): 5−11
- Чеботарев Д.Ф. Особенности заболевания почек в пожилом и старческом возрасте. В кн. Е. М. Тареев (ред.). Основы нефрологии. М., «Медицина», 1972: 816−831
- Чихладзе Н.М., Фаворова О. О., Гусев Д. Е. и др. Изучение характера поражения аорты и ее магистральных ветвей у больных неспецифическим аортоартериитом с различным генотипом в области главного комплекса гистосовместимости. Кардиология. 2005- 6: 31 34
- Шальнова С.А. Проблемы лечения артериальной гипертонии. Кардиоваскул. терапия и профилактика. 2003- 3: 17−21
- Шальнова С.А., Деев А. Д., Оганов Р. Г., Шестов Д. Б. Роль систолического и диастолического артериального давления в прогнозе смертности от сердечно-сосудистых заболеваний. Кардиоваскул. терапия и профилактика. 2002- 1: 10- 15
- Шилов Е.М., Козловская Н. Л., Метелева Н. А. и соавт. Клинические проявления нефропатии, связанной с антифосфолипидным синдромом, при первичном антифосфолипидном синдроме. Тер. арх. 2003- 6: 22 27
- Шляхто Е.В., Конради А. О., Захаров Д. В., Рудоманов О. Г. Структурно-функциональные изменения миокарда у больных гипертонической болезнью. Кардиология 1999- 2: 49 55
- Щербак А.В., Балкаров И. М., Козловская Л. В. и соавт. Фибринолитическая активность мочи как показатель поражения почек при нарушении обмена мочевой кислоты. Тер. архив 2001- 6: 34 37
- Adhiyaman V., Asghar М., Оке A. et al. Nephrotoxicity in the elderly due to co-prescription of angiotensin-converting enzyme inhibitors and nonsteroidal anti-Inflammatory drugs. J. R. Soc. Med. 2001- 94: 512 514
- Afzali B., Haydar A.A., Vinen K. et al. Beneficial effects of statins for the kidney: the evidence moves from mouse to man. Nephrol. Dial. Transplant. 2004- 19: 1032 -1036
- AHA Scientific Statement. Renal considerations in angiotensin converting enzyme therapy. Circulation 2001- 104: 1985- 1991
- Ahmed A., Nampoory M.R., Sheikh M., Johny K.V. Renal artery stenosis in patients with peripheral vascular disease in Kuwait. Med. Princ. Pract. 2005- 14(6): 386−389
- Alam M.G., Barri Y.M. Systolic blood pressure is the main etiology for poorly controlled hypertension. Am. J. Hypertens. 2003- 16:140 -143
- Alcazar J.M., Marin R., Gomez-Campedra F. et al. Clinical charasteristics of ischaemic renal disease. Nephrol. Dial. Transplant. 2001- 16 (Suppl. 1): 74−77
- Alcazar J.M., Rodicio J.L. Ischemic nephropathy: clinical characteristics and treatment. Am. J. Kidney Dis. 2000- 36(5): 883 893
- Alderman M.H., Cohen H., Madhavan S., Kivlighn S. Serum uric acid and cardiovascular events in successfully treated hypertensive patients. Hypertension 1999- 34: 144−150
- Anderson W.P., Woods R.L. Intrarenal effects of angiotensin II in renal artery stenosis. Kidney Int. 1987- 31 (Suppl. 20): S157 S167
- Anderstam B., Katzarski K., Bergstrom J. Serum levels of NG, NG-dymethyl-L-arginine, a potential endogenous nitric oxide inhibitor oxide in dialysis patients. J. Am. Soc. Nephrol. 1997- 8: 1437 1442
- Appel R.G., Bleyer A.J., Reavis S., Hansen K.J. Renovascular disease in older patients beginning renal replacement therapy. Kidney Int. 1995- 48: 171 176
- Aqel R.A., Zoghbi G.J., Baldwin S.A. et al. Prevalence of renal artery stenosis in high-risk veterans referred to cardiac catheterization. J. Hypertens. 2003- 21: 1157 -1162
- Arima S. Role of angiotensin II and endogenous vasodilators in the control of glomerular hemodynamics. Clin. Exp. Nephrol. 2003- 7: 172−178
- Arima S., Kohagura K., Abe M., Ito S. Mechanisms that control glomerular hemodynamics. Clin. Exp. Nephrol. 2001- 5: 55 61
- Asherson R.A., Noble G.E., Hughes G.R.V. Hypertension, renal arteries stenosis and the primary antiphospholipid syndrome. J. Rheumatol. 1991- 18: 1413−1415
- Atkins R.C. The epidemiology of chronic kidney disease. Kidney Int. 2005- 67 (Suppl. 94): S14-S18
- Auchus R.A. Aldo is back: recent advances and unresolved controversies in hyperaldosteronism. Curr. Opin. Nephrol. Hypertens. 2003- 12: 153 -158
- Aviles B., Ubeda I., Blanco J, Barrientos A., Pauci-immune extracapillary glomerulonephritis and atheromatous embolization. Am. J. Kidney Dis. 2002- 40(4): 847−851
- Baboolai K., Evans C., Moore R.H. Incidence of end-stage renal disease in medically treated patients with severe bilateral atherosclerotic renovascular disease. Am. J. Kidney Dis. 1998- 31(6): 971−977
- Badawy O., Wierzbicki A.S., Hilton R. Combination fibrate-statin therapy for the treatment of severe hypertriglyceridemia in renal disease. Int. J. Clin. Pract. 2003- 57(3): 249−251
- Baigent C., Landray M., Warren M. Statin therapy in kidney disease populations: potential benefits beyond lipid lowering and the need for clinical trials. Curr. Opin. Nephrol. Hypertens. 2004- 13: 601 -605
- Bakris G.L., Lass N., Gaber A.O. et al. Radiocontrast medium-induced declines in renal function: a role for oxygen free radicals. Am. J. Physiol. 1990- 258: F115 -F120
- BaIachandran K.P., Oldroyd K.G. Recovery of normal diurnal variation of blood pressure following renal artery stenting. J. Hum. Hypertens. 2003- 17(2): 147 -150
- Baraldi A., Ballestri M., Rapana R et al. Acute renal failure of medical type in an elderly population. Nephrol. Dial. Transplant. 1998- 13 (Suppl. 7): 25 29
- Basaria S., Fred H.L. Flash pulmonary oedema heralding renal artery stenosis. Circulation 2002- 105: 899
- Bates M.C., Rashid M., Campbell J.E. et al. Factors influencing the need for target vessel revascularization after renal artery stenting. J. Endovasc. Ther. 2006- 13(5): 569−577
- Belland R.J., Quellete S.P., Gieffers J., Byrne G.I. Chlamydia pneumoniae and atherosclerosis. Cell Microbiol. 2004- 6(2): 117−127
- Berkels R., Taubert D., Bartels H. et al. Amlodipine increases endothelial nitric oxide by dual mechanisms. Pharmacology 2004- 70(1): 39 45
- Blaine E.H., Davis J.O. Evidence for a renal vascular vascular mechanism in renin release: new observation with graded stimulation by aortic constriction. Circulation. Res. 1971- 28 29 (Suppl. 2): 118 — 126
- Blaine E.H., Davis J.O., Prewitt R.I. Evidence for a renal vascular receptor in control of renin secretion. Am. J. Physiol. 1971- 220: 1593−1597
- Bloch M.J., Trost D.A., Whitmer J. et al. Ostial renal artery stent placement in patients 75 years of age or older. Am. J. Hypertens. 2001- 14: 983 988
- Bloch M.J., Trost D.W., Pickering T.G. et al. Prevention of recurrent pulmonary oedema in patients with bilateral renovascular disease through renal artery stent placement. Am. J. Hypertens. 1999- 12: 1 7
- Bofinger A., Hawley C., Fisher P. et al. Polymorphisms of the renin-angiotensin system in patients with multifocal renal arterial fibromuscular dysplasia. J. Hum. Hypertens. 2001- 15(3): 185−190
- Bolander J.E. 2nd, Carter C.B. Cholesterol embolization in renal allografts. J. Am. Soc. Nephrol. 1996- 7(1): 18−22
- Bostom A.J., Culleton B.F. Hyperhomocysteinemia in chronic renal disease. J. Am. Soc. Nephrol. 1999- 10: 891 -900
- Bottinger E.P., Bitzer M. TGF-p signaling in renal disease. J. Am. Soc. Nephrol. 2002- 13: 2600−2610
- Brewster U.C., Setaro J.F., Perazella M.A. The renin-angiotensin-aldosterone system: cardiorenal effects and implications for renal and cardiovascular disease states. Am. J. Med. 2003- 326: 15−24
- Brezis M., Rosen S. Hypoxia of the renal medulla its implication for the disease. N. Engl. J. Med. 1995- 332: 647 — 655
- Briguorl C., Manganelli F., Scarpato P. et al. Acetylcysteine amd contrast-agent nephrotoxicity. J. Am. Coll. Cardiol. 2002- 40: 298−303
- Brook R., Julius S. Autonomic imbalance, hypertension and cardiovascular risk. Am. J. Hypertens. 2000- 13: 112S 122S
- Brown N.J., Kim K.S., Chen Y.Q. et al. Synergistic effect of adrenal steroids and angiotensin II on plasminogen activator inhibitor-1 production. J. Clin. Endocrinol. Metab. 2000- 85: 336 344
- Brunner H.R., Gavras H. Pathophysiologycal concepts of renpavscular hypertension. Contr. Nephrol. 1976- 3: 20−29
- Brunner H.R., Kirshman J.D., Sealey J.E., Laragh J.H. Hypertension of renal origin. Evidence for two different mechanisms. Science 1971- 174: 1344 1346
- Bruns F.J., Segal D.P., Alder S. Control of cholesterol embolization by discontinuation of anticoagulant therapy. Am. J. Med. Sci. 1978- 275: 105−108
- Buller C.E., Nogareda J.G., Ramanathan K. et al. The profile of cardiac patients with renal artery stenosis. J. Am. Coll. Cardiol. 2004- 43: 1606−1613
- Burt V.L., Whelton P., Rocella E.J. et al. Prevalence of hypertension in US adults population. Results from the Third National Health and Nutrition Survey. Hypertension 1995- 25: 305 313
- Burton C.J., Combe C., Walls J., Harris K.P.G. Secretion of chemokines and cytokines by tubular epithelial cells in response to proteins. Nephrol. Dial Transplant. 1999- 14: 2628−2633
- Cabili S., Teachman I., Goor Y. Reversal of gangrenous lesions in the blue toe syndrome with lovastatin a case report. Angiology 1993- 44: 821 — 825
- Cai H., Harrison D.G. Endothelial dysfunction in cardiovascular disease: the role of oxidant stress. Circ. Res. 2000- 87: 840 844
- Campo A., Boero R., Stratta P., Quarello F. Selective stenting and the course of atherosclerotic renovascular nephropathy. J. Nephrol. 2002- 15: 525 529
- CAPRIE Steering Committe A randomized, blinded trial of clopidogrel versus aspirin in patients at risk of ishaemic events (CAPRIE). Lancet 1996- 348: 1329 -1339
- CAPTURE. Randomized, placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE study. Lancet 1997- 349: 1429−1435
- Cardoso de Carvalho F., Bregagnollo E., Santos Silva V. et al. Frequency of coronary artery disease in patients with renal artery stenosis without clinical manifestations of coronary insufficiency. Am. J. Hypertens. 2006- 19(11): 11 251 128
- Chabrier G., Simon C., Cherfan J. et al. Acute renal insufficiency induced by captopril disclosing renal artery stenosis in a solitary kidney. Rev. Med. Interne. 1985- 6: 58−61
- Chade A.R., Krier J.D., Rodriguez-Porcel M. et al. Comparison of acute and chronic antioxidant interventions in experimental renovascular disease. Am. J. Physiol. Renal Physiol. 2004- 286(6): F1079- 1086
- Chade A.R., Rodriguez-Porcel M., Herrmann J. et al. Antioxidant intervention blunts renal injury in experimental renovascular disease. J. Am. Soc. Nephrol. 2004- 15(4): 958−966
- Chade A.R., Rodriguez-Porcel M., Herrmann J. et al. Beneficial effects of antioxidant vitamins on the stenotic kidney. Hypertension 2003- 42(4): 605 612
- Chade A.R., Zhu X., Mushin O.P. et al. Simvastatin promotes angiogenesis and prevents microvascular remodeling in chronic renal ischemia. FASEB J. 2006- 20(10): 1706−1708
- Chambless L.E., Folsom A.R., Clegg L.X. et al. Carotid wall thickness is predictive of incident clinical stroke: the Atherosclerosis Risk in Communities (ARIC) study. Am. J. Epidemiol. 2000- 151: 478 487
- Chiche L., Kieffer E., Sabatier J. et al. Renal autotransplantation for vascular disease: late outcome according to etiology. J. Vase. Surg. 2003- 37(2): 353−361
- Chobanian A.V., Bakris G.L., Black H.R. et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure: The JNC VI Report. J.A.M.A. 2003- 289: 2560 2571
- Choudri A., Cleland J.G.F., Rowlands P.C. et al. Unsuspected renal artery stenosis in peripheral vascular disease. Br. Med. J. 1990- 301: 1197- 1198
- Chuang S.-Y., Chou P., Hsu P.-F. et al. Presence and progression of abdominal obesity are predictors of future high blood pressure and hypertension. Am. J. Hyper. 2006- 19: 788−795
- Coen G., Manni M., Giannoni M.F. et al. Ischemic nephropathy in an elderly nephrologic and hypertensive population. Am. J. Nephrol. 1998- 18(3): 221−227
- Cosio F.G., Zager R.A., Sharma H.M. Atheroembolic renal disease causes hypocomplementemia. Lancet 1985- 2: 118−121
- Coulie P., De Plaen J.F., van Ypersele de Strihou C. Captopril-induced acute reversible renal failure. Nephron 1983- 35: 108 111
- Cusi D., Barlassina C., Azzani T. et al. Polymorphisms of a-adducin and salt-sensitivity in patients with essential hypertension. Lancet 1997- 349: 1338 1339
- D’Agati V. The many masks of focal segmental glomerulosclerosis. Kidney Int. 1994- 46: 1223−1241
- Darger L.F., Andrade L., Barros De Toledo J.F. et al. Renal effects of N-acetylcysteine in patients at risk for contrast nephropathy: decrease in oxidant stress-mediated renal tubular injury. Nephrol. Dial. Transplant. 2004- 19: 1803 -1807
- Davis B.A., Crook J.E., Vestal R.E., Oates J.A. Prevalence of renovascular hypertension in patients with grade III or IV hypertensive retinopathy. N. Engl. J. Med. 1979- 301: 1273−1276
- Dean R.H., Foster J.H. Criteria for the diagnosis of renovascular hypertension. Surgery 1973- 74: 926−929
- De Jong P.E., Brenner B.M. From secondary to primary prevention of progressive renal disease: the case for screening for albuminuria. Kidney Int. 2004- 66: 2109 -2118
- Devoy M.A., Tomson C.R., Edmunds M.E. et al. Deterioration in renal function associated with angiotensin converting enzyme inhibitor therapy is not always reversible. J. Intern. Med. 1992- 232: 493−498
- Dominiczak A., Isles C., Gillen G., Brown J.J. Angiotensin converting enzyme inhibition and renal insufficiency in patients with bilateral renovascular disease. J. Hum. Hypertens 1988- 2: 53 56
- Domrongkitchaiporn S., Sritara P., Kitiyakara C. et al. Risk factors for development of decreased kidney function in a southeast Asian population: a 12-year cohort study. J. Am. Soc. Nephrol. 2005- 16: 791 799
- Drexler H., Hornig B. Endothelial dysfunction in human disease. J. Moll. Cell. Cardiol. 1999- 31: 51 -60
- Ducher M., Cerutti C., Marquand A. et al. How to limit screening of patients for atheromatous renal artery stenosis in two-drug resistant hypertension? J. Nephrol. 2005- 18: 161 -165
- Duclos J., Goeke H., Opazo M. Flash pulmonary oedema: when the kidney causes the deconpensation of the heart. Revista Medica de Chile 2002- 130: 1033 1036
- Ducloux D., Jamali M., Chalopin J.M. Chronic congestive heart failure associated with bilateral renal artery stenosis. Clin. Nephrol. 1997- 48: 54 55
- Eddy A. Molecular insights into renal interstitial fibrosis. J.Am.Soc.Nephrol. 1996- 7: 2495−2508
- Edwards M.S., Craven T.E., Burke G.L. et al. Renovascular disease and the risk of adverse coronary events in the elderly: a prospective, population-based study. Arch. Intern. Med. 2005- 165(2): 207−213
- Edwards M.S., Hansen K.J., Craven T.E. et al. Associations between renovascular disease and prevalent cardiovascular disease in the elderly: a population-based study. Vase. Endovascular Surg. 2004- 38: 25 35
- Edwards M.S., Hansen K.J., Craven T.E. et al. Relationships between renovascular disease, blood pressure, and renal function in the elderly: a population-based study. Am. J. Kidney Dis. 2003- 41(5): 990−996
- El Nahas A.M., Bello A.K. Chronic kidney disease: the global challenge. Lancet 2005- 365: 331 -340
- Elkonen M., Beregi J.P., Dekluader G. et al. A prospective study of helical computed tomography versus angiography for the detection of renal artery stenosis in hypertensive patients. J. Hypertens. 1996- 14: 525 528
- ESH-ESC Guidelines Committee. ESH-ESC guidelines for the management of arterial hypertension. J. Hypertens. 2003- 21: 1011 1053
- Eylwe W.R., Clark M.D., Garman J.E. et al. Angiography of the renal areas including comparative study of renal areas including a comparative study of renal arterial stenoses in patients with and without hypertension. Radiology 1962- 78: 879 892
- Faber J.E., Brody M.E. Afferent renal nerve-dependent hypertension following acute renal artery stenosis in the conscious rat. Circ. Res. 1985- 57: 676 688
- Fagard R.H., Van den Enden M Treatment and blood pressure control in isolated systolic hypertension vs diastolic hypertension in primary care. J. Hum. Hypertens. 2003- 17:681 -687
- Farquharson C.A.J., Butler R., Hill A. et al. Allopurinol improves endothelial dysfunction in chronic heart failure. Circulation 2002- 106: 221 -226
- Fatica R.A., Port F.K., Young E.W. Incidence trends and mortality in end-stage renal disease attributed to renovascular disease in the United States. Am. J. Kidney Dis. 2001- 37: 1184 1190
- Feder W., Auerbach R. «Purple toes»: an uncommon sequela of oral Coumadin drug therapy. Ann. Intern. Med. 1961- 55: 911−917
- Fine M.J., Kapoor W., Falanga V. Cholesterol crystal embolization: a review of 221 cases in the English literature. Angiology. 1987- 38: 769 784
- Forette F., Seux M.L., Staessen J.A. et al. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 1998- 352:1347 -1351
- Fort J. Chronic renal failure: a cardiovascular risk factor. Kidney Int. 2005- 99 (Suppl.): S25-S29
- Garg A.X., Kiberd B.A., Clark W.F. et al. Albuminuria and renal insufficiency prevalence guides population screening: results from the NHANES III. Kidney Int. 2002- 61:2165−2175
- Garg J.P., Elliott W.J., Folker A. et al. Resistant hypertension revisited: a comparison of two university-based cohorts. Am. J. Hypertens. 2005−18 (5 Pt.1): 619−626
- Gephardt G.N., Tubbs R., Novick A.C. et al. Renal artery stenosis, nephrotic range proteinuria, and focal and segmental glomerulosclerosis. Cleveland Clin. Q. 1984- 51:371 -376
- Gillies A.H., Carney S.L., Smith A.J., Waga S.M. Adjunctive effect of salt restriction on antihypertensive efficacy. Clin. Exp. Pharmacol. Physiol. 1984- 11 (4): 395 -398
- Goerre S., Staehli C., Shaw S., Luscher T.F. Effect of sigarette smoking and nicotine on plasma endothelin-1 levels. J. Cardiovasc. Pharmacol. 1995- 26: S236 -238
- Goldblatt H., Lynh J., Hanzal R.F., Summerville W.W. Studies on experimental hypertension. The production of persistent elevation of systolic blood pressure by means of renal ischemia. J. Exp. Med. 1934- 59: 347 378
- Goldman M., Thoua Y., Dhaene M, Toussaint C. Necrotising glomerulonephritis associated with cholesterol microemboli. Br. Med. J. 1985- 290: 205−206
- Gray B.H., Olin J.W., Childs M.B. et al. Clinical benefit of renal artery angioplasty with stenting for the control of the recurrent and refractory congestive heart failure. Vase. Med. 2002- 7: 275 279
- Greenberg A., Bastacky S.I., lobal A. et al. Focal segmental glomerulosclerosis associated with nephrotic syndrome in cholesterol atheroembolism: clinicopathological correlations. Am. J. Kidney Dis. 1997- 29: 334 344
- Grimbert P., Fiquer-Kempf B., Coudol P. et al. Genetic study of renal artery fibromuscular dysplasia. Arch. Mai. CoeurVaiss. 1998- 91(8): 1069−1071
- Grossman A., Eckland D., Price P., Edwards C.R. Captopril: reversible renal failure with severe hyperkalaemia. Lancet. 1980- 1: 712
- Guerin A.P., Blacher J., Pannier B. et al. Impact of aortic stiffness attenuation on survival of patients in end-stage renal disease. Circulation 2001- 103: 987 992
- Gupta B.K., Spinowitz B.S., Charytan C., Wahl S.J. Cholesterol crystal embolization-associated renal failure after therapy with recombinant tissue-type plasminogen activator. Am. J. Kidney Dis. 1993- 659 662
- Haider A.W., Larson M.G., Franklin S.S., Levy D. Systolic blood pressure, diastolic blood pressure, and pulse pressure as predictors of risk for congestive heart failure in the Framingham Heart Study. Ann. Intern. Med. 2003- 138:10 -16
- Hakeyama H., Miramuri I., Fujita T. et al. Vascular aldosterone, biosynthesis and a link to angiotensin ll-induced hypertrophy of vascular smooth muscle cells. J. Biol. Chem. 1994- 269: 24 316−24 370
- Hamaguchi A., Kim S., Ohta K. et al. Transforming growth factor-?1 and phenotypic modulation in the kidney of hypertensive rats. Hypertension 1995- 26: 199−207
- Hammerschmith D., Greenberg D., Yamada C. et al. Cholesterol and atheroma lipids activate complement and stimulate granulocytes. J. Lab. Clin. Med. 1981- 98: 68 77
- Hannedouche T., Godin M., Fries D., Fillastre J.P. Acute renal thrombosis induced by angiotensin-converting enzyme inhibitors in patients with renovascular hypertension. Nephron 1991 — 57: 230 231
- Hansen K.J. Prevalence of ischemic nephropathy in the atherosclerotic population. Am. J. Kidney Dis. 1994- 24: 615 621
- Hansen K.J., Cherr G.S., Craven T.E. et al. Management of ischemic nephropathy: dialysis-free survival after surgical repair. J. Vase. Surg. 2000- 32(3): 472−481
- Hansen K.J., Edwards M.S., Craven T.E. et al. Prevalence of renovascular disease in the elderly: a population-based study. J. Vase. Surg. 2002- 36(3): 443 451
- Hasegawa M., Kawashima S., Shikano M. et al. The evaluation of corticosteroid therapy in conjunction with plasma exchange in the treatment of renal cholesterol embolic disease. A report of 5 cases. Am. J. Nephrol. 2000- 20(4): 263−267
- Higashi Y., Sasaki S., Nakagawa K., et al. Endothelial function and oxidative stress in renovascular hypertension. N. Engl. J. Med. 2002- 346: 1954 1962
- Hilgers K.F., Hartner A., Porst M. et al. Monocyte chemoattractant protein-1 and macrophage infiltration in hypertensive kidney injury. Kidney Int. 2000- 58: 2408 -2419
- Hilgers K.F., Hartner A., Porst M. et al. Monocyte chemoattractant proteln-1 and macrophage infiltration in hypertensive kidney injury. Kidney Int. 2000- 58(6): 2408−2419
- Holley K.E., Hunt J.K., Brown A.L. et al. Renal artery stenosis. A clinical-pathologic study in normotensive and hypertensive patients. Am. J. Med. 1964- 37: 14−22
- Hommels M.J., van der Ven A.J., Kroon A.A. et al. C-reactive protein, atherosclerosis and kidney function in hypertensive patients. J. Hum. Hypertens. 2005- 19(7): 521−526
- Horita Y., Tadokoro M., Taura K. et al. Relationship between carotid artery intima-media thickness and atherosclerotic renal artery stenosis in type 2 diabetes with hypertension. Kidney Blood Press. Res. 2002- 25(4): 255 259
- Hozawa A., Ohkubo T., Nagai K. et al. Prognosis of isolated systolic and isolated diastolic hypertension as assessed by self-measurement of blood pressure at home: the Ohasama study. Arch. Intern. Med. 2000- 160:3301 3306
- Hricik D.E., Browning P.J., Kopelman R. et al. Captopril-induced functional renal insufficiency in patients with bilateral renal-artery stenoses or renal-artery stenosis in a solitary kidney. N. Engl. J. Med. 1983- 308: 373 6
- Hunt S.C., Cook N.R., Oberman A. et al. Angiotensinogen genotype, sodium reduction, weight loss, and prevention of hypertension: trials of hypertension prevention phase II. Hypertension 1998- 32: 393−401
- Jacobson H.R. Ischemic nephropathy: an overlooked clinical entity? Kindney Int. 1988- 34: 729−743
- Jager A., Kostense P.J., Nijpens G. et al. Serum homocysteine levels are associated with development of microalbuminuria: the Hoorn study. Arterioscler. Thromb. Vase. Biol. 2001 — 21: 74 81
- Johansson M., Friberg P. Role of the sympathetic nervous system in human renovascular hypertension. Curr. Hypertens. Rep. 2000- 2(3): 319 326
- Johansson M., Herlitz H., Jensen G. et al. Increased cardiovascular mortality in hypertensive patients with renal artery stenosis. Relation to sympathetic activation, renal function and treatment regimens. J. Hypertens. 1999- 17: 1743- 1750
- Johnson L.W., Esente P., Giambortolomei A. et al. Peripheral vascular complications of coronary angioplasty by the femoral and brachial techniques. Cathet. Cardiovasc. Diagn. 1994- 31: 165- 172
- Johnson R.J., Alpers C.E., Yoshimura A. et al. Renal injury from angiotensin II-mediated hypertension. Hypertension. 1992- 19: 464−474
- Jones D.B., lannaccone P.M. Atheromatous emboli in renal biopsies. Am. J. Pathol. 1975- 78: 261 -271
- Jooles J.A., Koomans H.A. Causes and consequences of increased sympathetic activity in renal disease. Hypertension 2004- 43: 699 706
- Kaatee R., Beek F.J., Lange de E.E. et al. Renal artery stenosis: detection and quantification with spiral CT angiography versus optimized digital subtraction angiography. Radiology 1997- 205: 121 127
- Kalra P.A., Guo H., Kausz A.T. et al. Atherosclerotic renovascular disease in United States patients aged 67 years or older: risk factors, revascularization, and prognosis. Kidney Int. 2005- 68(1): 293−301
- Kang D.-H., Nakagawa T., Feng L. et al. A role of uric acid in the progression of renal disease. J. Am. Soc. Nephrol. 2002- 13: 2888 2897
- Karagiannis A., Douma S., Vogiatzis K. et al. The relationship between the sympathetic nervous system and tha renin-angiotensin system in renovascular hypertension. Acta Cardiol. 1994- 49(5): 425−434
- Karagiannis A., Tziomalos K., Dona K. et al. Bilateral renal artery stenosis and primary aldosteronism in a diabetic patient. Q.J.M. 2005- 98: 913−915
- Kashyap V.S., Sepulveda R.N., Bena J.F. et al. The management of renal artery atherosclerosis for renal salvage: does stenting help? J. Vase. Surg. 2007- 45(1): 101−108
- Kasinath B.S., Corwin H.L., Bidani A.K. et al. Eosinophilia in the diagnosis of atheroembolic renal disease. Am. J. Nephrol. 1987- 7: 173 177
- Kasinath B.S., Lewis E.J. Eosinophilia as a clue to the diagnosis of atheroembolic renal disease. Arch. Intern. Med. 1987- 147: 1384 1385
- Kawasaki T., Delea C.S., Bartter F.C., Smith H. The effect of high-sodium and low-sodium intakes on blood pressure and other relate variables in human subjects with arterial hypertension. Am. J. Med. 1978- 64: 193−198
- Kellerman P. S. Cellular and metabolic of chronic ischemia on kidney function. Semin. Nephrol. 1996- 16: 33−42
- Kidney Disease Outcome Quality Initiative. Clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am. J. Kidney Dis. 2002- 39 (Suppl. 2): S1 S246
- Kim S., Ohta K., Hamaguchi A. et al. Contribution of renal angiotensin II type I receptor to gene expressions in hypertension-induced renal injury. Kindney Int. 1994- 46: 1346−1358
- Klag M.J., Whelton P.K., Randall B.L. et al. End-stage renal disease in African-American and white men: 16-year MRFIT findings. J.A.M.A. 1997- 277: 1293 -1298
- Kon V., Jabs K. Angiotensin in atherosclerosis. Curr. Opin. Nephrol Hypertens. 2004- 13: 291 -297
- Korsakas S., Mohaupt M.G., Dinkel H.P. et al. Delay of dialysis in end-stage renal failure: prospective study on percutaneous renal artery interventions. Kidney Int. 2004- 65(1): 251−258
- Krumme B., Mann J.F.E. Atherosclerotic renal artery stenosis in 2001 are we less confused than before? Nephrol. Dial. Transplant. 2001- 16: 2124 — 2127
- Kumagai H., Katoh S., Hiroshawa K. et al. Renal tubulointerstitial injury in weanling rats with hyperhomocysteinemia. Kidney Int. 2002- 62: 1219−28
- Kuroda S., Nishida N., Uzu T. et al. Prevalence if renal artery stenosis in autopsy patients with stroke. Stroke 2000- 31: 61 65
- Lakusic N., Mahovic D., Ciglenecki N. et al. Reversible impairment of renal function during treatment with lisinopril, an ACE-inhibitor (case report). Lijec. Vjesn. 2001- 123:245−248
- Lederman R.J., Mendelsohn F.O., Santos R. et al. Primary renal artery stenting: characteristics and outcomes after 363 procedures. Am. Heart J. 2001- 142: 314 -323
- Lerman L.O., Nath K.A., Rodriguez-Porcel M. et al. Increased oxidative stress in experimental renovascular hypertension. Hypertension 2001- 37: 541 546
- Leskinen Y., Lehtimaki T., Loimaala A. et al. Homocysteine and carotid } atherosclerosis in chronic renal failure the confounding effect of renal function. Atherosclerosis. 2004- 175: 315 — 323
- Lever A.F., Beretta-Piccolli C., Brown J.J. et al. Exchangeable sodium and volume status in renovascular hypertension. Br. Med. J. 1981- 283: 1 -15
- Licata G., Scaglione R., Guillet C. et al. Double-blind, controlled study of rilmenidine versus hydrochlorthizide in mild hypertension: clinical and renal hemodynamical evaluation. J. Hum. Hypertens. 1993- 7: 153−157
- Lins R.L., Daelemans R., Dratwa M. et al. Acceptability of rilmenidine and long-term surveillance of plasma concentrations in hypertensive patients with renal insufficiency. Am. J. Med. 1989- 87: 41S -45S
- Liss P., Nygren A., Hansell P. et al. Hypoperfusion in the renal outer medulla after injection of contrast media in rats. Acta Radiol. 1999- 40: 521 527
- Liu B.C., Tang R.N., Feng Y. et al. A single Chinese center investigation of renal artery stenosis in 141 consecutive cases with coronary angiography. Am. J. Nephrol. 2004- 24(6): 630−634
- London G.M., Drueke T.M. Atherosclerosis and arteriolosclerosis in chronic renal failure. Kidney Int. 1997- 51: 1678−1695
- Losito A., Fagugli R.M., Zampi I. et al. Comparison of target organ damage in renovascular and essential hypertension. Am. J. Hypertens. 1996- 9(11): 10 621 067
- Losito A., Parente B., Cao P.G. et al. ACE gene polymorphism and survival in atherosclerotic renovascular disease. Am. J. Kidney Dis. 2000- 35(2): 211−215
- Losito A., Selvi A., Jeffery S. et al. Angiotensin-converting enzyme gene l/D polymorphism and carotid artery disease in renovascular hypertension. Am. J. Hypertens. 2000- 13(2): 128−133
- Luscher T.F., Keller H.M., Imhof H.G. et al. Fibromuscular hyperplasia: extension of the disease and therapeutic outcome: results of the University Hospital Zurich Cooperative Study on Fibromuscular Hyperplasia. Nephron 1986- 44: 109 114
- Lynggaard F., Jespersen C.M. Reversible renal failure due to captopril in a patient with renal artery stenosis in a solitary functioning kidney. Ugeskr. Laeger. 1985- 147: 1549−1550
- Mailloux L.U., Levey A.S. Hypertension in patients with chronic renal disease. Am. J. Kidney Dis. 1998- 32: S120 S141
- Mailloux L.U., Napolitano B., Belucci A.G. et al. Renal vascular disease causing end-stage renal disease, incidence, clinical correlates and outcomes: a 20-year clinical experience. Am. J. Kidney Dis. 1994- 24: 622 629
- Mann S.J., Pickering T.G., Sos T.A. et al. Captopril renography in the diagnosis of renal artery stenosis: accuracy and limitations. Am. J. Med. 1991- 90: 30−40
- Mannesse C.K., Blankenstijn P.J., Man in t’Veld A.J., Schalekamp M.A.D.H. Renal failure and cholesterol crystal embolization: a report of 4 surviving cases and review of literature. Clin. Nephrol. 1991 — 36: 240 245
- Mansoor G.A., Tendler B.E., Anwar Y.A. et al. Coexistence of atherosclerotic renal artery stenosis with primary hyperaldosteronism. J. Hum. Hypertens. 2000- 14: 151 153
- Mansoor S., Shah A., Scoble J.E. 'Flash pulmonary oedema' a diagnosis for both the cardiologist and the nephrologist? Nephrol. Dial. Transplant. 2001- 16: 1311 -1313
- Maron D.J., Fazio S., Linton M.R.F. Current perspectives on statins. Circulation. 2000- 101: 207−213
- Mason J.C., Hilton P.J. Reversible renal failure due to captopril in a patient with transplant artery stenosis. Case report. Hypertension 1983- 5: 623 627
- Massy Z.A., Guijarro C. Statins: effects beyond cholesterol lowering. Nephrol. Dial. Transplant. 2001- 16: 1738 1741
- Mazzali M., Hughes J., Kim Y.-H. et al. Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension 2001- 38: 1101 -1106
- Meany T.F., Dustan H.P., McCormack L.J. Natural history of renal arterial disease. Radiology. 1968- 91: 881
- Mehta S.R., Yusuf S., Peters R.J.G. et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 2001- 358: 527 533
- Messerli F.H., Genest J., Nowaczynski W. et al. Hypertension with renal artery stenosis: humoral, hemosynamic and histopathologic factors. Am. J. Cardiol. 1975- 36(5): 702−795
- Metcalfe W., Reid A.W., Geddes C.C. Prevalence of angiographic atherosclerotic renal artery disease and its relationship to the anatomical extent of peripheral vascular atherosclerosis. Nephrol. Dial. Transplant. 1999- 14(1): 105−108
- Meyrier A. Renal vascular lesions in the elderly: nephrosclerosis or atheromatous renal disease? Nephrol. Dial. Transplant. 1996- 11 (Suppl. 9): 45 52
- Meyrier A., Hill G.S., Simon P. Ischemic renal disease. New insights into old entities. Kidney Int. 1998- 54: 2 13
- Miller P.L., Rennke H.G., Meyer T.W. Glomerular hypertrophy accelerates hypertensive glomerular injury in rats. Am. J. Physiol. 1991- 261: F459 F465
- Miralles M., Cairols M., Cotillas J. et al. Value of Doppler parameters in the diagnosis of renal artery stenosis. J. Vase. Surg. 1996- 23: 428 435
- Missouris C.G., Barley J., Jeffery S. et al. Genetic risk for renal artery stenosis: association with deletion polymorphism in angiotensin 1-converting enzyme gene. Kidney Int. 1996- 49(2): 534−537
- Missouris C.G., Belli A.M., MacGregor G.A. «Apparent» heart failure: a syndrome caused by renal artery stenosis. Heart 2000- 83: 152 155
- Mittal B.R., Kumar P., Arora P. et al. Role of captopril renography in the diagnosis of renovascular hypertension. Am. J. Kidney Dis. 1996- 28: 209 213
- Miura Y., Satz T., Abex K. Studies of plasma renin activity in patients with renovvascular hypertension. Japan. Circ. J. 1972- 36: 617 621
- Modai D., Cohen N., Weissgarten J., Segal B., Pik A. Symptomatic renal artery stenosis superimposed on chronic glomerulonephritis. Isr J Med Sci 1985- 21: 366 -369
- Modi K.S., Rao V.K. Atheroembolic renal disease. J. Am. Soc. Nephrol. 2001- 12: 1781 1787
- Moran K., Mulhall J., Kelly D. et al. Morphological and strctural changes in regional intrarenal blood flow induced by graded renal ischemia. J. Urol. 1992- 148: 463 -466
- Morganti A., Bencini C., Del Vecchio C., Strata M. Treatment of atherosclerotic renal artery stenosis. J. Am. Soc. Nephrol. 2002- 13: S187 -S189
- Morii T., Fujita H., Narita T. et al. Association of monocyte chemoattractant protein-1 with renal tubular damage in diabetic nephropathy. J. Diabetes Complications. 2003- 17(1): 11−15
- Mosso L., Carvajal C., Gonzales A. et al. Primary aldosteronism and hypertensive disease. Hypertension 2003- 42: 161−165
- Mounier-Vehier C., Haulon S., Lions C. et al. Renal atrophy in atherosclerotic renovascular disease: gradual changes 6 months after successful angioplasty. J. Endovasc. Ther. 2002- 9(6): 863−872
- Mounier-Vehier C., Lions C., Devos P. et al. Cortical thickness: an early morphological marker of atherosclerotic renal disease. Kidney Int. 2002- 61: 591 -598
- Mui K.W., Sleeswijk M., van den Hout H. et al. Incidental renal artery stenosis is an independent predictor of mortality in patients with peripheral vascular disease. J. Am. Soc. Nephrol. 2006- 17(7): 2069−2074
- Murphy S.W., Barret B.J., Parfrey P. S. Contrast nephropathy. J. Am. Soc. Nephrol. 2000- 11: 177−182
- National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Tratment Panel III). J.A.M.A. 2001- 285: 2486 2497
- Olbricht C.J., Paul K., Prokop M. et al. Minimally invasive diagnosis of renal artery stenosis by spiral computed tomography angiography. Kidney Int. 1995- 48: 1332 -1337
- Olin J.W. Renal artery disease: diagnosis and management. Mount Sinai J. Med. 2004- 71(2): 73−85
- Olin J.W., Melia M., Young J.R. et al. Prevalence of atherosclerotic renal artery stenosis in patients with atherosclerosis elsewhere. Am. J. Med. 1990- 88 (1N): N46-N51
- Park J.S., Park J.H., Kang J.Y. et al. Hyperfibrinogenemia is an independent risk factor for atherosclerotic renal artery stenosis. Am. J. Nephrol. 1999- 19(6): 649 -654
- Park S., Jung J.H., Seo H.S. et al. The prevalence and clinical predictors of atherosclerotic renal artery stenosis in patients undergoing coronary angiography. Heart Vessels. 2004- 19(6): 275 279
- Pauletto P., Da Ros S., Faggin E. et al. Antiatherogenic action of nitrendipine in hypercholesterolemic rabbits: changes in aortic macrophage accumulation and smooth muscle cell phenotype. J. Vase. Res. 1996- 33(1): 5−12
- Pearce J.D., Craven B.L., Craven T.E. et al. Progression of atherosclerotic renovascular disease: A prospective population-based study. J. Vase. Surg. 2006- 44(5): 955−962
- Pedersen E.B. Angiotensin-converting enzyme inhibitor renography: pathophysiological, diagnostic and therapeutic aspects in renal artery stenosis (review). Nephrol. Dial Transplant. 1994- 9: 482−492
- Pedersen E.B. New tools in diagnosing renal artery stenosis. Kindney Int. 2000- 57:2657 2677
- Perna A., Ruggenenti P., Testa A. et al. ACE genotype and ACE inhibitors induced renoprotection in chronic proteinuric nephropathies. Kidney Int. 2000- 57: 274 -281
- Perry H.M. Jr., Davis B.R., Price T.R. et al. Effect of treating isolated systolic hypertension on the risk of developing various types and subtypes of stroke: the Systolic Hypertension in the Elderly Program (SHEP). J.A.M.A. 2000- 284: 465 -471
- I.Peterson M.J., Rundquist B., Johansson M. et al. Increased cardiac sympathetic drive in renovascular hypertension. J. Hypertens. 2002- 20(6): 1181 1187
- Pickering T.G., Herman L., Devereux R.B. et al. Recurrent pulmonary edema in hypertension due to bilateral renal artery stenosis: treatment by angioplasty or surgical revascularization. Lancet 1988- 2: 551 552
- Pizzolo F., Mansueto G., Minniti S. et al. Renovascular disease: effect of ACE gene deletion polymorphism and endovascular revascularization. J. Vase. Surg. 2004- 39(1): 140−147
- Planken I.I.L., Rietveld A.P. Rapid onset pulmonary oedema (flash oedema) in renal artery stenosis. Neth. J. Med. 1998- 52: 116 119
- PIoin P.-F., Rossignol P., Bobrie G. Atherosclerotic renal artery stenosis: to treat conservatively, to dilate, to stent or to operate? J. Am. Soc. Nephrol. 2001- 12: 2190−2196
- Plouin P.F., Darne B., Azizi M. et al. Renovascular hypertension: diagnostic and therapeuric strategy. Rev. Med. Interne. 1992- 13(2): 127−134
- Poutasse E.F., Humphries A.W., McCormack L.J., Corcoran A.C. Bilateral stenosis of renal arteries and hypertension. Treatment by arterial homografts. J.A.M.A. 1956- 161- 419−423
- Quaschning T., Schomig M., Wanner C. et al. Non-insulin-dependent diabetes mellitus and hypertriglyceridemia impair lipoprotein metabolism in chronic hemodialysis patients. J. Am. Soc. Nephrol. 1999- 10: 332−341
- Qureshi A.I., Suri M.F., Mohammad Y. et al. Isolated and borderline isolated systolic hypertension relative to long-term risk and type of stroke: a 20-year follow-up of the national health and nutrition survey. Stroke 2002- 33: 2781 2788
- Radermacher J., Chavan A., Schaffer J. et al. Detection of sighnificant renal artery stenosis with color Doppler sonography: combining extrarenal and intrarenal approaches to minimize technical failure. Clin. Nephrol. 2000- 53: 333 343
- Radermacher J., Haller H. The right diagnostic work-up: investigating renal and renovascular disorders. J. Hypertens. 2003- 21 (Suppl. 2): S19 S24
- Reid J. Rilmenidine: a clinical overview. Am. J. Hypertens. 2000- 13: 84S 88S
- Remuzzi G., Weening J.J. Albuminuria as early test for vascular disease. Lancet 2005- 365: 556 557
- Reynolds H.R., Tunick P.A., Benenstein R.J. et al. Frequency of severe renal artery stenosis in patients with severe thoracic aortic plaque. Am. J. Cardiol. 2004- 94: 844 846
- Rice J.C., Spence J.S., Yetman D.L., Safirstein R. Monocyte chemoattractant protein-1 expression correlates with monocyte infiltration in the post-ischemic kidney. Ren. Fail. 2002- 24(6): 703−723
- Rich M.W., Crecelius C.A. Incidence, risk factors and clinical course of acute renal insufficiency after cardiac catheterization in patients 70 years of age and older. Arch. Intern. Med. 1990- 150: 1237−1242
- Ridker P.M., Rifai N., Pfeffer M.A. et al. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol And Recurrent Events trial. Circulation 1998- 98: 839 844
- Riehl J., Schmitt H., Bongartz D. et al. Renal artery stenosis: evaluation with colour duplex ultrasonography. Nephrol. Dial. Transplant. 1997- 12: 1608- 1614
- Rigatelli G. Aortoiliac angiography during coronary artery angiography detects significant occult aortoiliac and renal artery atherosclerosis in patients with coronary atherosclerosis. Int. J. Cardiovasc. Imaging. 2004- 20(4): 299−303
- Rigatelli G., Rigatelli G. Predictors of renal artery stenosis in patients with normal renal function undergoing coronary angiography. Minerva Cardioangiol. 2006- 54(1):145−149
- Rimmer J.M., Gennari J. Atherosclerotic renovacular disease and progressive renal failure. Ann. Intern. Med. 1993- 118: 712−719
- Robinson T.G., Carr S.J. Cardiovascular autonomic dysfunction in uremia. Kidney Int. 2002- 62: 1921 1932
- Robles N.R., Romero J., Gomez Casero L. et al. Hyperhomocytseinemia in patients with mild chronic renal failure. Eur. J. Intern Med. 2005- 16(5): 334 338
- Romero J.C., Reckelhoff J.F. State-of-the-Art lecture: role of angiotensin II and oxidative stress in essential hypertension. Hypertension 1999- 34: 943 949
- Ross R. Atherosclerosis: an inflammatory disease. N. Engl. J. Med. 1999- 340: 115−126
- Rossi A., Rossi G., Zanin L. et al. High prevalence of obstructive lesions of the extracranial carotid arteries in reno-vascular hypertension. G. Ital. Cardiol. 1990- 20(4): 291−299
- Ruggenenti P., Remuzzi G. Malignant vascular disease of the kidney: nature of the lesions, mediators of disease progression and the case for bilateral nephrectomy. Am. J. Kidney Dis. 1996- 27(4): 459 475
- Ruggenenti P., Schieppati A., Remuzzi G. Progression, remission, regression of chronic renal diseases. Lancet 2001- 357: 1601 1608
- Ruilope L.M., Salvetti A., Jamerson K. et al. Renal function and intensive lowering of blood pressure in hypertensive subjects of the Hypertension Optimal Treatment (HOT) Study. J. Am. Soc. Nephrol. 2001- 12: 218−225
- Rump L.C., Amann K., Orth S., Ritz E. Sympathetic overactivity in renal disease: a window to understand progression and cardiovascular complications of uremia. Nephrol. Dial Transplant. 2000- 15: 1735 1748
- Rundback J.H., Murphy T.P., Cooper C., Weintarub J.L. Chronic renal ischemia: pathophysiological mechanisms of cardiovascular and renal hypertension. J. Vase. Interv. Radiol. 2002- 13: 1085−1092
- Rushton A.R. The genetics of fibromuscular dysplasia. Arch. Intern. Med. 1980- 140(2): 233−236
- Sacks F.M., Svetkey L.P., Vollmer W.M. et al. for the DASH-Sodium Collaboration Research Group. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. N. Engl. J. Med. 2001−344:3−10
- Safian R.D., Textor S.C. Renal-artery stenosis. N. Engl. J. Med. 2001- 344: 431 -442
- Saklayen M.G., Gupta S., Suryaprasad A., Azmeh W. Incidence of atheroembolic renal failure after coronary angiography. A prospective study. Angiology. 1997- 48(7): 609−613
- Sawicki P.T., Didjurgeit U., Muhlhauser I. Smoking is associated with progression of diabetic nephropathy. Diabetes Care 1994- 17: 126 131
- Sawicki P.T., Keiser S., Heinemann L. et al. Prevalence of renal artery stenosis in diabetes mellitus: an autopsy study. J. Intern. Med. 1991- 229: 489 492
- Scanu P., Hurault de Ligny B., Ryckelynck J.P. Reversible acute renal insufficiency with combination of enalapril and diuretics in a patient with a single renal-artery stenosis. Nephron 1987- 45: 321 322
- Schepkens H., Vanholder R., Billiouw J.M., Lameire N. Life-threatening hyperkalemia during combined therapy with angiotensin-converting enzymeinhibitors and spironolactone: an analysis of 25 cases. Am. J. Med. 2001- 110: 438 -441
- Shammas N.W., Kapalis M.J., Dippel E.J. et al. Clinical and angiographic predictors of restenosis following renal artery stenting. J. Invasive Cardiol. 2004- 16: 10−13
- Slovut D.P., Olin J.W. Fibromuscular dysplasia. N. Engl. J. Med. 2004- 350: 1862 1871
- Strandberg T.E., Pyorala K., Cook T.J. et al. Mortality and incidence of cancer during 10-year follow-up of the Scandinavian Simvastatin Survival Study (4S). Lancet 2004- 364: 771 111
- Struthers A.D. Impact of aldosterone on vascular pathophysiology. Congest. Heart Fail. 2002- 8: 18−22
- Swartbol P., Thorvinger B.O.T., Parsson H., Norgrren L. Renal artery stenosis In patients with peripheral vascular disease and its correlation to hypertension. A retrospective study. Int. Angiol. 1992- 11: 195 199
- Symonides B., Januszewicz A., Rowinski O. et al. Plasma fibrinogen as a risk factor for restenosis after percutaneous transluminal renal angioplasty in patients with atherosclerotic renal artery stenosis. J. Cardiovasc. Risk. 1999- 6(4): 269−272
- Tan K.T., van Beek E.J.R., Brown P.W.G. et al. Magnetic resonance angiography for the diagnosis of renal artery stenosis: a meta-analysis. Clin. Radiol. 2002- 57: 617−624
- Tanemoto M., Saitoh H., Satoh F. et al. Predictors of undiagnosed renal artery stenosis among Japanese patients with risk factors of atherosclerosis. Hypertens. Res. 2005- 28(3): 237−242
- Tepel M., Zidek W. N-acetylcysteine in nephrology: contrast nephropathy and beyond. Curr. Opin. Nephrol. Hypertens. 2004- 13: 649 654
- Textor S.C. Atherosclerotic renovascular disease as a cause of end-stage renal disease: cost considerations. Blood Purif. 1996- 14: 305−314
- Textor S.C. Pathophysiology of renal failure in renovascular disease. Am. J. Kidney Dis. 1994- 24: 642 651
- Textor S.C., Wilcox C. Ischemic nephropathy/azotemic renovascular hypertension. Semin. Nephrol. 2000- 20: 489 502
- Textor S.C., Wilcox C.S. Renal artery stenosis: a common, treatable cause of renal failure? Annu Rev. Med. 2001- 52: 421−442
- Thadani R., Pascual M., Nickeleit V. et al. Preliminary description of focal segmental glomerulosclerosis in patients with renovascular disease. Lancet 1996- 347: 231 -233
- Thadhani R.I., Camargo C.A., Xavier R.J. et al. Atheroembolic renal failure after invasive procedures. Natural history based on 52 histologically proven cases. Medicine (Baltimore). 1995- 74(6): 350−358
- The 4S Study Group. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study. Lancet1994- 1383−1389
- The DECODE study group on behalf of the European Diabetes Epidemiology Group. Glucose tolerance and cardiovascular mortality. Arch. Intern. Med. 2001- 161: 397−404
- The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Effects of immediate versus delayed antihypertensive therapy on outcome in the Systolic Hypertension in Europe Trial. J. Hypertens. 2004- 22: 847 857
- Tollefson D.F.J., Ernst C.B. Natural history of atherosclerotic renal artery stenosis associated with aortic disease. J. Vase. Surg. 1991- 14: 327−331
- Tripathi K., Srivastava P.K., Tewari N.N., Mishra P. S. Reversible renal failure in auto transplanted restenosed bilateral renal artery stenosis with captopril. J. Assoc. Physicians India 1985- 33: 617
- Truong L.D., Farhood A., Tasby J., Gillum D. Experimental chronic renal ischemia: morphologic and immunological studies. Kidney Int. 1992- 41: 1676 1689
- Tuomilehto J., Rastenyte D., Birkenhager W.H. et al. Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trial Investigators. N. Engl. J. Med. 1999- 340: 677 684
- Tuttle K.R., Zalunardo K.R. Atherosclerotic renal artery stenosis: current status and future directions. Curr. Opin. Nephrol. Hypertens. 2003- 13: 613 621
- UK Prospective Diabetes Study Group. Effect of intensive blood-glucose control with metformin on complications in owerweight patients with type 2 diabetes (UKPDS 33). Lancet 1998- 352: 837 853
- Uzu T., Inoue T., Fujii T. et al. Prevalence and predictors of renal artery stenosis in patients with myocardial infarction. Am. J. Kidney Dis. 1997- 29: 733 738
- Vasbinder G.B., Nelemans P.J., Kessels A.G. et al. Accuracy of computed tomographic angiography and magnetic resonance angiography for diagnosing renal artery stenosis. Ann. Intern. Med. 2004- 141: 674 682
- Vaughan J.E. jr. Renovascular hypertension Kidney Int. 1985- 27: 811 -827
- Vaziri N.D. Dyslipidemia of chronic renal failure: the nature, mechanisms and potential consequences. Am. J. Physiol. Renal. Physiol. 2006- 290(2): F262 -272
- Verdecchia P., Schillaci G., Reboldi G.-P. Relation between serum uric acid and risk of cardiovascular disease in essential hypertension. The PIUMA Study. Hypertension 2000- 36: 1072 1078
- Vetrovec G.W., Landwehr D.M., Edwards V.L. et al. Incidence of renal artery stenosis in hypertensive patients undergoing coronary angiography. J. Interven Cardiol. 1989- 2: 69−76
- Vidt D.G., Eisele G., Gephardt G.N. et al. Atheroemblic renla disease. Association with renal artery stenosis. Cleveland Clin. J. Med. 1989- 56: 407−413
- Voyaki S.M., Staessen J.A., Thijs L. et al. Follow-up of renal function in treated and untreated older patients with isolated systolic hypertension. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. J. Hypertens. 2001- 19: 511 519
- Wada T., Yokoyama H., Kobayashi K. Chemokines: new target molecules in renal diseases. Clin. Exp. Nephrol. 2000- 4: 273−280
- Wada T., Yokoyama H., Su S. et al. Monitoring urinary levels of monocyte chemotactic and activating factor reflects disease activity of lupus nephritis. Kidney Int. 1996- 49: 761 -767
- Wang Y., Ho D.S., Chen W.H. et al. Prevalence and predictors of renal artery stenosis in Chinese patients with coronary artery disease. Intern. Med. J. 2003- 33(7): 280 285
- Ward M.M., Studenski S. Clinical prognostic factors in lupus nephritis: the importance of hypertension and smoking. Arch. Intern. Med. 1992- 152: 2028 -2088
- Watson P. S., Hadjipetrou P., Cox S.V. et al. Effect of renal artery stenting on renal function and size in patients with atherosclerotic renovascular disease. Circulation. 2000- 102: 1671 1677
- Whelton P.K., Appel L.J., Espeland M.A. et al. Sodium restriction and weight loss in the treatment of hypertension in older persons. A randomized controlled trial of non-pharmacological interventions in the elderly (TONE). J.A.M.A. 1998- 279: 839 -846
- Wilms G., Marchal G., Peene P., Baert A.L. The angiographic incidence of renal artery stenosis in the atherosclerotic population. Eur. J. Radiol. 1990- 10: 195 -197
- Wilson D.M., Salazer T.L., Farkouh M.E. Eosinophiluria in atheroembolic renal disease. Am. J. Med. 1991- 91 (2): 186−189
- Wolf G. Molecular mechanisms of angiotensin II in the kidney- emerging role in the progression of renal disease: beyond haemodynamics. Nephrol. Dial. Transplant. 1998- 13: 1131 1142
- Wollenweber J., Sheps S.G., Davis G.D. Clinical course of atherosclerotic renovascular disease. Am. J. Cardiol. 1968- 91: 60 71
- Wong F.K., Chan S.K., Ing T.S., Li C.S. Acute renal failure after streptokinase therapy in a patient with acute myocardial infarction. Am. J. Kidney Dis. 1995- 26: 508−510
- Woolfson R.G., Lachman H. Improvement in renal cholesterol emboli syndrome after simvastatin. Lancet 1998- 351: 1331 1332
- Wright J.R., Duggal A., Thomas R. et al. Clinicopathological correlation in biopsy-proven atherosclerotic nephropathy: implications for renal functional outcome in atherosclerotic renovascular disease. Nephrol. Dial. Transplant. 2001- 16(4): 765 770
- Wright J.R., Shurrab A.E., Cheung C. et al. A prospective study of the determinants of renal functional outcome and mortality in atherosclerotic renovascular disease. Am. J. Kidney Dis. 2002- 39(6): 1153−1161
- Wynckel A., Ebikili B., Melin J.P. et al. Long-term follow-up of acute renal failure caused by angiotensin converting enzyme inhibitors. Am. J. Hypertens. 1998- 11: 1080- 1086
- Ying W.Z., Sanders P.W. Dietary salt modulates renal production of transforming growth factor-beta in rats. Am. J. Physiol. 1998- 274: F635 F641
- Young J.H., Klag M.J., Muntner P. et al. Blood pressure and decline in kidney function: findings from the Systolic Hypertension in the Elderly Program (SHEP). J. Am. Soc. Nephrol. 2002- 13: 2776 2782
- Yusuf S., Hawken S., Ounpuu S. et al. Obesity and the risk of myocardial infarction in 27 000 participants from 52 countries: a case-control study. Lancet 2005- 366: 1640−1649
- Yusuf S., Mehta S.R., Zhao F. et al. Early and late effects of clopidogrel in patients with acute coronary syndromes. Circulation 2003- 107: 966 972
- Yusuf S., Witte J., Friedeman L. Overview of results of randomized trials in heart disease in heart disease- unstable angina, heart failure, primary prevention with aspirin and risk factor modifications. JAMA 1988- 260: 2259 2263
- Yuyun M.F., Khaw K.T., Luben R. et al. A prospective study of microalbuminuria and incident coronary heart disease and its prognostic significance in a British population: the EPIC-Norfolk study. Am. J. Epidemiol. 2004- 159: 284 293
- Zeller T., Muller C., Frank U. et al. Stent angioplasty of severe atherosclerotic ostial renal artery stenosis in patients with diabetes mellitus and nephrosclerosis. Catheter. Cardiovasc. Interv. 2003- 58: 510−515
- Zhang Y., Ge J.B., Qian J.Y., Ye Z.B. Prevalence and risk factors of atherosclerotic renal artery stenosis in 1200 Chinese patients undergoing coronary angiography. Nephron Clin. Pract. 2006- 104(4): c185-c192
- Zierler R.E., Bergelin R.O., Polissar N.L. et al. Carotid and lower extremity arterial disease in patients with renal artery atherosclerosis. Arch. Intern. Med. 1998- 158: 761 767
- Zuccala A., Zuccheli P. A renal disease frequently found at postmortem, but rarely diagnosed in vivo. Nephrol. Dial. Transplant. 1997- 12: 1762 1767